Adipocyte-derived Chemerin Rescues Lipid Overload-Induced Cardiac Dysfunction

Ruimin Liu,Yinying Han,Chenglong Huang,Mengqian Hou,Rui Cheng,Shujin Wang,Xi Li,Jie Tian

DOI: https://doi.org/10.1016/j.isci.2023.106495

IF: 5.8

2023-01-01

iScience

Abstract:Chemerin, an adipocyte-secreted protein, has been recently suggested to be linked to metabolic syndrome and cardiac function in obese and diabetes mellitus. This study aimed to investigate the potential roles of adipokine chemerin on high fat-induced cardiac dysfunction. Chemerin (Rarres2) knockout mice, which were fed with either a normal diet or a high-fat diet for 20 weeks, were employed to observe whether adipokine chemerin affected lipid metabolism, inflammation, and cardiac function. Firstly, we found normal metabolic substrate inflexibility and cardiac function in Rarres2(-/-) mice with a normal diet. Notably, in a high-fat diet, Rarres2(-/-) mice showed lipotoxicity, insulin resistance, and inflammation, thus causing metabolic substrate inflexibility and cardiac dysfunction. Furthermore, by using in vitro model of lipid-overload cardiomyocytes, we found chemerin supplementation reversed the lipid-induced abnormalities above. Here-in, in the presence of obesity, adipocyte-derived chemerin might function as an endogenous cardioprotective factor against obese-related cardiomyopathy.